Back to search

Effect of prostaglandin synthetase inhibitors on platelet aggregation and thromboxane production in diabetes mellitus.

Data up to Jan 2025

Published1984
Citations4
References16

Total Citations Per Year

Abstract

References (16)

Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

1962 • 4,273 citations

The Pathogenesis of Atherosclerosis

1976 • 2,000 citations

Drugs which inhibit prostaglandin biosynthesis.

1974 • 1,325 citations

Increased platelet thromboxane synthesis in diabetes mellitus.

1981 • 260 citations

Selective inhibition by mepacrine of the release of “rabbit aorta contracting substance” evoked by the administration of bradykinin

1972 • 249 citations

Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets.

1977 • 215 citations

Increased Synthesis of Prostaglandin-E-like Material by Platelets from Patients with Diabetes Mellitus

1977 • 195 citations

Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats.

1980 • 183 citations

Platelet hyperaggregation and increased plasma level of von Willebrand factor in diabetics with retinopathy

1975 • 167 citations

Diabetes and Atherosclerosis: an Overview

1981 • 146 citations

Thromboxane production and platelet aggregation in diabetic subjects with clinical complications

1980 • 114 citations

Stimulated Platelet Aggregation, Thromboxane B2 Formation and Platelet Sensitivity to Prostacyclin - A Critical Evaluation

1981 • 62 citations

Effect of Vitamin E on Platelet Aggregation in Diabetes Mellitus

1984 • 56 citations

Increased Platelet Arachidonic Acid Metabolism in Diabetes Mellitus

1981 • 34 citations

Platelet Abnormalities in Experimental Diabetes

1979 • 22 citations

Cyclic nucleotide phosphodiesterase and aggregation in platelets from diabetic rats

1982 • 11 citations

Cited By (0)

Loading...